Antitumor activity of sugar-modified cytosine nucleosides.
about
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cellsA Nucleoside Anticancer Drug, 1-(3-C-Ethynyl-β-D-Ribo-Pentofuranosyl)Cytosine, Induces Depth-Dependent Enhancement of Tumor Cell Death in Spread-Out Bragg Peak (SOBP) of Proton BeamA rapid synthetic route to conformationally restricted [5,5]-bicyclic nucleoside-amino acid conjugates.Antimetabolites and cancer: emerging data with a focus on antifolates.High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignanciesInactivation of Lactobacillus leichmannii ribonucleotide reductase by 2',2'-difluoro-2'-deoxycytidine 5'-triphosphate: covalent modificationSubstrates and Inhibitors of SAMHD1.3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.Influence of organic solvents on catalytic behaviors and cell morphology of whole-cell biocatalysts for synthesis of 5'-arabinocytosine laurate.Preparation and evaluation of polymeric microparticulates for improving cellular uptake of gemcitabine.Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites.Inhibition of HIF-1alpha by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo.Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression.Delivery of Gemcitabine Prodrugs Employing Mesoporous Silica Nanoparticles.DNA lesion bypass polymerases and 4'-thio-β-Darabinofuranosylcytosine (T-araC).Synthesis and antitumor activity of a heterodinucleotide of BVDU and gemcitabine.Development of an antitumor adenosine analog, 3''-ethynyladenosine.Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd).Synthesis of novel derivatives of 5-hydroxymethylcytosine and 5-formylcytosine as tools for epigenetics.A novel biocatalytic approach to acetylation of 1-β-D-arabinofuranosylcytosine by Aspergillus oryzae whole cell in organic solvents.Diastereoselective synthesis of (+/-)-1',4'-dimethyluridine.Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine.Synthesis of purine homo-N-nucleosides modified with coumarins as free radicals scavengers.Transient expression of Drosophila melanogaster deoxynucleoside kinase gene enhances cytotoxicity of nucleoside analogs.Nucleosides and nucleotides. 232. Synthesis of 2'-C-methyl-4'-thiocytidine: unexpected anomerization of the 2'-keto-4'-thionucleoside precursor.Reprofiling of full-length phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides toward antiproliferative agents: Synthesis, antiproliferative activity, and molecular docking study.Preparation of intravenous injection nanoformulation via co-assemble between cholesterylated gemcitabine and cholesterylated mPEG: enhanced cellular uptake and intracellular drug controlled release.A general method for N-glycosylation of nucleobases promoted by (p-Tol)2SO/Tf2O with thioglycoside as donor.Understanding the behavior of Thermomyces lanuginosus lipase in acylation of pyrimidine nucleosides possessing 2'-substituent.Complete conformational space of the potential HIV-1 reverse transcriptase inhibitors d4U and d4C. A quantum chemical studyChemical Synthesis of Carbocyclic Analogues of Nucleosides
P2860
Q24653228-A70C80D9-4C0A-44D8-883B-67BA40F6EB96Q28553660-EEB353C8-285E-4CCD-B677-34DE7C64FC49Q33359427-68137746-6600-4A85-8503-6E53AB585CBCQ33530405-53BFFF58-C054-45B7-AED1-F79655266C7DQ33566475-3E395817-8DCE-4A9A-9946-DC5C687B30CAQ33791851-64D2356B-D8E9-4B81-9EE6-2A34BE79818BQ34548496-0FCB9476-BC37-4FF1-8FDB-49D52CE95C01Q35217985-F9E20B65-AAF1-4D01-8ED7-927C084FB0BAQ35227898-A8D6BB3D-009E-481B-BB5C-C5D6C89D6D34Q35979136-ABC671E4-B1A9-417E-98FB-5B8774B5A463Q36628679-F01F9CBB-D36C-4F68-8B55-A9C591517040Q36965074-CF63E4E6-4F7F-4F23-B168-C41091FA85F1Q36994110-2355D57B-75A3-4332-A763-B5121B658614Q37701947-B936CB6A-A8B3-4D9E-898F-FAC136FC7513Q38261947-C55C66DC-2E6F-49D9-8C79-7A24B907DF2EQ38775652-C5E0B4D0-4EE5-43DF-B131-4EAFA3281952Q39907624-8F0FA818-2DC2-4724-BDFA-ABF0E918BEC1Q39969804-60E1B5E4-3C44-497F-BDB3-00B1476C7C31Q40037904-2FDB9838-F370-4EB9-82BE-22FB006475EBQ40358223-049A91EA-064D-4907-A18E-6B0561B44E98Q41880011-EE4D4C99-201C-4842-9318-1C3546FE6EE8Q42491505-8F7BBB8B-2E97-4982-BD2C-7E57A04320C5Q43196972-E47BC29B-4D59-43E4-BBC2-1D34274E44E8Q43289065-8A419F10-667C-4FB3-8179-BFF027BEB74BQ45405297-48F981AB-EE53-46FB-A638-5593FE7B3B68Q45861091-72282130-AAAD-4360-B907-CFD7A43D89F9Q46912363-68F2552F-57F8-4226-A699-BECEACE158B4Q48328758-1A8D5B98-D87C-4770-9D7E-D19C46E8D3FBQ50930245-0F4DC125-8FE7-42DD-B590-19DB7A86ABA1Q50955561-D1C0BE64-12BE-4012-8A33-450EEF74E9BDQ53484521-A18CE01C-D0F4-4C25-861E-5F27F86AAAE6Q56170868-7ED8163F-A4E2-4324-AD9B-47A434925044Q56864675-78200286-C954-47A3-B959-AE10FFA5C1EB
P2860
Antitumor activity of sugar-modified cytosine nucleosides.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antitumor activity of sugar-modified cytosine nucleosides.
@ast
Antitumor activity of sugar-modified cytosine nucleosides.
@en
type
label
Antitumor activity of sugar-modified cytosine nucleosides.
@ast
Antitumor activity of sugar-modified cytosine nucleosides.
@en
prefLabel
Antitumor activity of sugar-modified cytosine nucleosides.
@ast
Antitumor activity of sugar-modified cytosine nucleosides.
@en
P2860
P1433
P1476
Antitumor activity of sugar-modified cytosine nucleosides.
@en
P2093
Akira Matsuda
Takuma Sasaki
P2860
P304
P356
10.1111/J.1349-7006.2004.TB03189.X
P577
2004-02-01T00:00:00Z